Roche Covid-19 Antibody Test Gets Emergency FDA Approval (1)

May 3, 2020, 4:19 PM UTC

Roche Holding AG became the latest company to win emergency U.S. approval for a coronavirus antibody test and promised a fast scale-up of the tool that policy makers hope will smooth the reopening of economies.

The Swiss giant expects production of the test to reach the high double-digit millions by June and pass the 100 million monthly threshold later this year. The test looks for antibodies in blood that have been raised to fight off the virus that causes Covid-19.

Roche’s version runs on a high-volume instrument that can produce a single result in 18 minutes and as many as ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.